Shows / Decera Clinical Education Oncology Podcast
Decera Clinical Education Oncology Podcast
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Decera Clinical Education. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
Episodes
Decera Clinical Education Oncology PodcastIncorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Spain
In this episode, Félix Guerrero Ramos, MD, PhD, FEBU, and Óscar Rodríguez-Faba, MD, discuss in Spanish the latest immuno-oncology developments in the treatment…
Decera Clinical Education Oncology PodcastExpert Answers to Pathologist Questions on New Biomarkers for Precision Therapy in Lung Cance
In this episode, Nathan Pennell, MD, PhD, and Laura J. Tafe, MD, provide medical oncology and pathology perspectives, respectively, when answering questions…
Decera Clinical Education Oncology PodcastApplication of Individualized Treatment for CLL/SLL: Novel Agents, Combinations, and Sequencing Therapy: FAQ
In this episode,William G. Wierda, MD, PhD, Jeremy S. Abramson, MD, MMSc, and Brian Hill, MD, PhD, answer questions focused on personalizing therapy for…
Decera Clinical Education Oncology PodcastPractical Insights on Key Data From ESMO 2020 Informing Precision Medicine in NSCLC
In this episode, Helena A. Yu, MD, and Maria E. Arcila, MD, provide medical oncology and pathology perspectives, respectively, on new data from ESMO 2020…
Decera Clinical Education Oncology PodcastImmunotherapy for Advanced HCC: Experts Answer Clinician Questions
Link to CME: Claim Credit In this episode, Amit G. Singal, MD, MS, and Lipika Goyal, MD, answer clinician questions on current best practices and emerging…
Decera Clinical Education Oncology PodcastIncorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From the Netherlands and the United Kingdom
In this episode, Thomas Powles, MBBS, MRCP, MD, and Michiel van der Heijden, MD, PhD, discuss key data on immune checkpoint inhibitors for urothelial carcinoma…
Decera Clinical Education Oncology PodcastIncorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From France
In this episode, Alain Ravaud, MD, PhD, and Marine Gross-Goupil, MD, PhD, discuss in French the latest immuno-oncology developments in the treatment of…
Decera Clinical Education Oncology PodcastMolecular Classification of Endometrial Carcinoma in the Clinic Today
In this episode, Mansoor Raza Mirza, MD, and Ana Oaknin, MD, PhD, discuss the implications of recent advances in the use of molecular testing and…
Decera Clinical Education Oncology PodcastAdvances in Immunotherapy for Endometrial Cancer
In this episode, Mansoor Raza Mirza, MD, and Ana Oaknin, MD, PhD, discuss the implications of recent advances in the use of immunotherapy for the treatment of…
Decera Clinical Education Oncology PodcastBiomarkers in Ovarian Cancer: Expert Discussion of Options for First-line Maintenance Therapy
In this episode, Isabelle Ray Coquard, MD, PhD and Bradley J. Monk, MD, FACS, FACOG, discuss current first-line maintenance therapy options for patients with…
Decera Clinical Education Oncology PodcastDevelopments in Acute Leukemias: Expert Answers to Clinician Questions
In this episode, David Marks, MD, PhD, and Stéphane de Botton, MD, answer questions from clinicians on management pearls for patients with acute leukemias…
Decera Clinical Education Oncology PodcastBiomarkers in Ovarian Cancer: Expert Discussion of BRCA Testing and Beyond
Listen to Prof Nicoletta Colombo and Bradley J. Monk, MD, FACS, FACOG, discuss current best practices for biomarker testing for your patients with advanced…
Decera Clinical Education Oncology PodcastExperts Discuss Evolving State-of-the-Art Management of Patients With HER2-Positive MBC
In this podcast episode, listen to breast cancer experts Thomas Bachelot, MD, PhD; Adam M. Brufsky, MD, PhD; and Cristina Saura, MD, PhD, discuss clinical…
Decera Clinical Education Oncology PodcastThe Art of Medicine: Clinical Considerations for Patients With Advanced RCC
In this episode, an expert medical oncology panel led by Elizabeth R. Plimack, MD, MS, with Brian A. Costello, MD, and Martin H. Voss, MD, discusses clinical…
Decera Clinical Education Oncology PodcastChronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 1
In this episode, Jeff P. Sharman, MD, Danielle M. Brander, MD, and Nicole Lamanna, MD, answer questions focused on the optimizing BTK inhibitor therapy for…
Decera Clinical Education Oncology PodcastChronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 3
In this episode, Jeff P. Sharman, MD, Danielle M. Brander, MD, and Nicole Lamanna, MD, answer audience questions from a live Webinar focused on optimal use of…
Decera Clinical Education Oncology PodcastClinical Considerations for <em>RET</em> Fusion–Positive NSCLC
In this podcast episode, listen to lung cancer experts Joshua Bauml, MD, a medical oncologist, and Dara L. Aisner, MD, PhD, a molecular pathologist, discuss…
Decera Clinical Education Oncology PodcastChronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 2
In this episode, Jeff P. Sharman, MD, Danielle M. Brander, MD, and Nicole Lamanna, MD, answer audience questions from a live Webinar focused on optimal use of…
Decera Clinical Education Oncology PodcastCAR T Cell Therapy for Lymphoma, Leukemia, and Myeloma: Experts Answer Clinician Questions
In this episode, Michael R. Bishop, MD; Daniel J. DeAngelo, MD, PhD; and Noopur Raje, MD, answer clinician questions on current best practices and emerging…
Decera Clinical Education Oncology PodcastPractical Application of Immuno-Oncology in RCC: Expert Discussion of Second-line Therapy and Beyond
In this episode, an expert medical oncology panel, led by Elizabeth R. Plimack, MD, with Brian A. Costello, MD, and Martin H. Voss, MD, discusses current best…
Decera Clinical Education Oncology PodcastFAQ on New Therapeutic Developments in Relapsed/Refractory Multiple Myeloma
In this episode, Jesús F. San-Miguel, MD, PhD; Paula Rodriguez-Otero, MD, PhD; and Prof. Dr. med. Katja Weisel answer questions focused on current and emerging…
Decera Clinical Education Oncology PodcastNew Advances in Relapsed/Refractory Multiple Myeloma: Frequently Asked Questions on Current and Emerging Treatments
In this episode, Natalie S. Callander, MD, and Shaji Kumar, MD, answer audience questions from a live CCO Webinar on relapsed/refractory myeloma regarding…
Decera Clinical Education Oncology PodcastPractical Application of Immuno-Oncology in RCC: Expert Discussion of Frontline Therapy
In this episode, Elizabeth R. Plimack, MD, MS; Brian A. Costello, MD; and Martin H. Voss, MD, discuss current best practices for the first-line treatment of…
Decera Clinical Education Oncology PodcastApplication of New Data in B-Cell Malignancies From ASCO and EHA 2020: Waldenström Macroglobulinemia, Mantle Cell Lymphoma, Hodgkin Lymphoma, and Diffuse Large B-Cell Lymphoma
In this episode, Jennifer R. Brown, MD, PhD, and John Allan, MD, discuss recent key clinical trial results in Waldenström macroglobulinemia, mantle cell…
Decera Clinical Education Oncology PodcastMET Exon 14 Mutation–Positive NSCLC: FAQ Part 1
In this episode, Luis Paz-Ares, MD, PhD; D. Ross Camidge, MD, PhD; and Karen L. Reckamp, MD, MS, address questions on MET exon 14 testing and selecting…
Decera Clinical Education Oncology PodcastMET Exon 14 Mutation–Positive NSCLC: FAQ Part 2
In this episode, Luis Paz-Ares, MD, PhD; D. Ross Camidge, MD, PhD; and Karen L. Reckamp, MD, MS, address questions on biomarking testing and the use of…
Decera Clinical Education Oncology PodcastImmunotherapy in SCLC: FAQ on Current Best Practice and Emerging Therapeutic Strategies
In this episode, Anna F. Farago, MD, PhD, and Taofeek K. Owonikoko, MD, PhD, answer questions focused on the topic of current and evolving use of immunotherapy…
Decera Clinical Education Oncology PodcastApplication of New Data in B-Cell Malignancies From ASCO and EHA 2020: CLL
In this episode, Jennifer R. Brown, MD, PhD, and John Allan, MD, discuss recent key clinical trial results in CLL presented at the 2020 annual meetings of the…
Decera Clinical Education Oncology PodcastFuture Treatment Strategies for Acute Myeloid Leukemia—Emerging Targeted Therapy Combinations and Beyond
In this episode, Naval G. Daver, MD, discusses promising investigational agents and treatment combinations in clinical trials for patients with newly diagnosed…
Decera Clinical Education Oncology PodcastTumor Agnostic TRK Inhibitor Therapy and NTRK Fusion Testing: Experts Answer Clinician Questions
In this episode, George D. Demetri, MD; Alexander Drilon, MD; and Pashtoon Kasi, MD, answer questions about NTRK fusion testing and TRK inhibitor therapy for…
Decera Clinical Education Oncology PodcastImproving Outcomes for Patients With CML With TKIs: FAQ Podcast
In this episode, Prof. Dr. med Tim Henrik Brümmendorf; Jorge Cortes, MD; and Carlo Gambacorti-Passerini, MD, answer questions focused on the optimal selection…
Decera Clinical Education Oncology PodcastApplication of Existing and Emerging Biomarkers for Immuno-Oncology Across Tumor Types: Answering Clinician Questions
In this episode, an expert medical oncology panel led by John L. Marshall, MD, with Jamie E. Chaft, MD, and Scot Niglio, MD, provides a brief overview on the…
Decera Clinical Education Oncology PodcastPrecision Therapy in Lung Cancer: FAQ on Biomarker Testing and Targeted Therapies
In this episode, Edward S. Kim, MD, FACP, and Leora Horn, MD, MSc, FRCPC, answer questions focused on biomarker testing and selecting targeted therapy for…
Decera Clinical Education Oncology PodcastPrecision Therapy in Lung Cancer: FAQ on Biomarkers for Immune Checkpoint Inhibitors
In this episode, Edward S. Kim, MD, FACP, and Leora Horn, MD, MSc, FRCPC, answer questions focused on current and evolving biomarkers for immune checkpoint…